Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response (Q40536409)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response |
scientific article published on April 2004 |
Statements
1 reference
Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response (English)
1 reference
William Larry Gluck
1 reference
Alan Yuen
1 reference
Alexandra M Levine
1 reference
Mark A Dayton
1 reference
Jon P Gockerman
1 reference
Jennifer Lucas
1 reference
Kimberly Denis-Mize
1 reference
Barbara Tong
1 reference
Dawn Navis
1 reference
Anita Difrancesco
1 reference
Sandra Milan
1 reference
Susan E Wilson
1 reference
Maurice Wolin
1 reference
1 April 2004
1 reference
1 reference
2253-2264
1 reference
Identifiers
1 reference